drugset / Trial / NCT00113685
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
Completed
209 enrolled
University of Washington
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2007-03
Outcome
Missed primary endpoint
paper Intent-to-treat analysis demonstrated no significant difference in ARDS-free survival (hazard ratio, 1.01; 95% confidence interval, 0.63-1.60). PMID 18283138 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic Saline-Dextran Solution | Other / unclassified | 250 ml | — |
| Subject | Lactated Ringer's Solution | Other / unclassified | 250 ml | Intravenous |